198 related articles for article (PubMed ID: 29808017)
1. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.
Sirniö P; Tuomisto A; Tervahartiala T; Sorsa T; Klintrup K; Karhu T; Herzig KH; Mäkelä J; Karttunen TJ; Salo T; Mäkinen MJ; Väyrynen JP
Br J Cancer; 2018 Jul; 119(2):213-219. PubMed ID: 29808017
[TBL] [Abstract][Full Text] [Related]
2. Serum MMP-8 and TIMP-1 predict prognosis in colorectal cancer.
Böckelman C; Beilmann-Lehtonen I; Kaprio T; Koskensalo S; Tervahartiala T; Mustonen H; Stenman UH; Sorsa T; Haglund C
BMC Cancer; 2018 Jun; 18(1):679. PubMed ID: 29929486
[TBL] [Abstract][Full Text] [Related]
3. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.
Sirniö P; Väyrynen JP; Klintrup K; Mäkelä J; Karhu T; Herzig KH; Minkkinen I; Mäkinen MJ; Karttunen TJ; Tuomisto A
Br J Cancer; 2019 Jan; 120(2):238-246. PubMed ID: 30563990
[TBL] [Abstract][Full Text] [Related]
4. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
[TBL] [Abstract][Full Text] [Related]
5. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer.
Väyrynen JP; Väyrynen SA; Sirniö P; Minkkinen I; Klintrup K; Karhu T; Mäkelä J; Herzig KH; Karttunen TJ; Tuomisto A; Mäkinen MJ
J Transl Med; 2019 Jun; 17(1):199. PubMed ID: 31196200
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer.
Suzuki Y; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Kondo T; Kitagawa Y
Ann Surg; 2018 Mar; 267(3):527-531. PubMed ID: 27984214
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
[TBL] [Abstract][Full Text] [Related]
9. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
10. Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator.
Chung YC; Chang YF
Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):369-73. PubMed ID: 12655256
[TBL] [Abstract][Full Text] [Related]
11. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
[TBL] [Abstract][Full Text] [Related]
13. Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.
Biasi F; Guina T; Maina M; Nano M; Falcone A; Aroasio E; Saracco GM; Papotti M; Leonarduzzi G; Poli G
PLoS One; 2012; 7(7):e41839. PubMed ID: 22848630
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.
Park JH; Powell AG; Roxburgh CS; Horgan PG; McMillan DC; Edwards J
Br J Cancer; 2016 Mar; 114(5):562-70. PubMed ID: 26859693
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
[TBL] [Abstract][Full Text] [Related]
17. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors.
Väyrynen JP; Vornanen J; Tervahartiala T; Sorsa T; Bloigu R; Salo T; Tuomisto A; Mäkinen MJ
Int J Cancer; 2012 Aug; 131(4):E463-74. PubMed ID: 21918979
[TBL] [Abstract][Full Text] [Related]
18. Quantitative data on red cell measures of iron status and their relation to the magnitude of the systemic inflammatory response and survival in patients with colorectal cancer.
McSorley ST; Tham A; Steele CW; Dolan RD; Roxburgh CS; Horgan PG; McMillan DC
Eur J Surg Oncol; 2019 Jul; 45(7):1205-1211. PubMed ID: 30850153
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
Holm M; Saraswat M; Joenväärä S; Ristimäki A; Haglund C; Renkonen R
PLoS One; 2018; 13(4):e0195354. PubMed ID: 29630649
[TBL] [Abstract][Full Text] [Related]
20. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]